Indications And Dose
Primary immunisation against pneumococcal infection ▶BY INTRAMUSCULAR INJECTION ▶Elderly: 0.5 mL for 1 dose, deltoid muscle is preferred site of injection in adults Immunisation against pneumococcal infection [in patients at increased risk] ▶BY INTRAMUSCULAR INJECTION ▶Child 2–17 years: 0.5 mL for 1 dose, dose should be administered at least 2 months after the last dose of the 13-valent pneumococcal polysaccharide conjugate vaccine (adsorbed), deltoid muscle is preferred site of injection in children and adults ▶Adult: 0.5 mL for 1 dose, deltoid muscle is preferred site of injection in adults, primary immunisation with the pneumococcal polysaccharide vaccine is not required when these patients reach 65 years of age Immunisation against pneumococcal infection [revaccination; booster dose in patients with no spleen, splenic dysfunction or chronic kidney disease] ▶BY INTRAMUSCULAR INJECTION ▶Child 7–17 years: 0.5 mL every 5 years, deltoid muscle is preferred site of injection in children and adults ▶Adult: 0.5 mL every 5 years, deltoid muscle is preferred site of injection in adults
PDF page 1408